查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2112655

2026-2034年全球病理學領域人工智慧市場規模、佔有率、趨勢和成長分析報告

Global AI In Pathology Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 201 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

全球病理學人工智慧市場預計將從2025年的1.5684億美元成長至2034年的12.323億美元，預計在2026年至2034年間以25.74%的複合年成長率成長。該市場正經歷快速成長，主要得益於人工智慧在診斷過程中的日益普及。病理學人工智慧能夠實現影像分析的自動化，進而提高疾病檢測的準確性和效率。癌症和其他慢性疾病的日益普及也是推動市場擴張的重要因素，因為醫療機構需要先進的診斷工具來改善病患的治療效果。

關鍵促進因素包括機器學習演算法的進步、醫療保健日益數位化以及對更快更準確診斷的需求。人工智慧驅動的病理解決方案透過分析大規模資料集和識別模式，幫助病理學家做出明智的決策。人工智慧與數位病理平台的整合也簡化了工作流程。此外，遠距病理服務的擴展也推動了市場成長。

由於人工智慧技術和數據分析領域的持續創新，該市場的未來前景仍然十分光明。更複雜演算法的開發以及與其他診斷工具的整合將進一步提升其功能。隨著醫療基礎設施的改善，新興市場預計將迎來顯著的成長機會。隨著精準醫療需求的持續成長，病理學領域的人工智慧市場預計將保持永續擴張。

我們的報告經過精心撰寫，旨在提供涵蓋廣泛行業和市場的全面且切實可行的洞察。每份報告都包含幾個關鍵組成部分，旨在幫助您全面了解市場環境：

市場概覽：本節對市場進行了清晰的說明，包括關鍵定義、分類以及當前行業格局的概述。

市場動態：本節詳細評估影響市場成長的主要促進因素、阻礙因素、機會和挑戰。內容涵蓋技術發展、法律規範和不斷變化的行業趨勢等因素。

市場區隔分析：本部分根據產品類型、應用、最終用戶和地區將市場系統性地分類為若干關鍵細分市場。本部分揭示了每個細分市場的表現、成長潛力和市場貢獻。

競爭格局：我們對主要市場參與企業進行了詳細評估，包括其市場定位、產品系列、策略舉措和財務表現。這有助於深入了解競爭趨勢和主要參與者所採取的策略。

市場預測：本部分是基於對指定預測期內市場規模和成長模式的數據進行展望。它綜合考慮了歷史趨勢、當前市場狀況和定量分析，以揭示未來預期趨勢。

區域分析：本部分全面回顧了主要地理區域的市場表現，並識別出高成長領域和區域趨勢，以更深入地了解區域市場機會。

新趨勢與新機會：識別關鍵市場趨勢、技術進步和新興投資機會。本部分重點在於潛在成長領域和未來產業趨勢。

客製化選項：我們提供靈活的報告客製化服務，以滿足您的特定需求。這包括額外的細分、國家/地區分析、競爭對手分析、客製化資料點或針對特定細分市場的洞察，以更好地支援您的策略決策。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章：全球病理學人工智慧市場：按產品分類

  • 市場分析、洞察與預測
  • 系統
  • 軟體服務

第5章：全球病理學人工智慧市場：按技術分類

  • 市場分析、洞察與預測
  • 機器學習和深度學習
  • 自然語言處理
  • 其他

第6章：全球病理學人工智慧市場：按應用領域分類

  • 市場分析、洞察與預測
  • 臨床應用
  • 藥物發現
  • 其他

第7章：全球病理學人工智慧市場：按最終用戶分類

  • 市場分析、洞察與預測
  • 醫院和診所
  • 生物技術和製藥公司
  • 其他

第8章：全球病理學人工智慧市場：按地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第9章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商情況（基於現有資訊）
  • 策略規劃

第10章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Koninklijke Philips NV
    • PathAI Inc
    • Aignostics GmbH
    • Hologic Inc
    • F. Hoffmann-La Roche Ltd
    • Aiforia Technologies Plc
    • Ibex Medical Analytics Inc
    • Paige Inc
    • Proscia Inc
    • Indica Labs Inc
    • FUJIFILM Healthcare Americas Corporation（formerly Capturing Inspirata Inc.'s Asset Portfolio）
簡介目錄
Product Code: VMR112116714

The global AI in pathology market size is expected to reach USD 1232.30 Million in 2034 from USD 156.84 Million in 2025, growing at a CAGR of 25.74% during 2026-2034.This market is witnessing rapid growth driven by the increasing adoption of artificial intelligence in diagnostic processes. AI in pathology enables automated image analysis, improving accuracy and efficiency in disease detection. The growing prevalence of cancer and other chronic diseases is significantly contributing to market expansion, as healthcare providers seek advanced diagnostic tools to enhance patient outcomes.

Key drivers include advancements in machine learning algorithms, increasing digitalization of healthcare, and the need for faster and more accurate diagnostics. AI-powered pathology solutions can analyze large datasets, identify patterns, and assist pathologists in making informed decisions. The integration of AI with digital pathology platforms is also improving workflow efficiency. Additionally, the expansion of telepathology services is supporting market growth.

Future prospects for this market remain highly promising, with continuous innovation in AI technologies and data analytics. The development of more sophisticated algorithms and integration with other diagnostic tools will enhance capabilities. Emerging markets are expected to offer significant growth opportunities due to improving healthcare infrastructure. As the demand for precision medicine continues to rise, the AI in pathology market is poised for sustained expansion.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Product

  • Systems
  • Software And Services

By Technology

  • Machine Learning And Deep Learning
  • Natural Language Processing
  • Others

By Application

  • Clinical Application
  • Drug Discovery
  • Others

By End-User

  • Hospitals And Clinics
  • Biotechnology And Pharma Companies
  • Others

COMPANIES PROFILED

  • Koninklijke Philips N.V., PathAI Inc., Aignostics GmbH, Hologic Inc., F. Hoffmann-La Roche Ltd, Aiforia Technologies Plc, Ibex Medical Analytics Inc., Paige Inc., Proscia Inc., Indica Labs Inc., FUJIFILM Healthcare Americas Corporation (formerly capturing Inspirata Inc.'s, asset portfolio)

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL AI IN PATHOLOGY MARKET: BY PRODUCT 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Product
  • 4.2. Systems Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Software And Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL AI IN PATHOLOGY MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Technology
  • 5.2. Machine Learning And Deep Learning Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Natural Language Processing Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL AI IN PATHOLOGY MARKET: BY APPLICATION 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast Application
  • 6.2. Clinical Application Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Drug Discovery Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL AI IN PATHOLOGY MARKET: BY END-USER 2022-2034 (USD MN)

  • 7.1. Market Analysis, Insights and Forecast End-user
  • 7.2. Hospitals And Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.3. Biotechnology And Pharma Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL AI IN PATHOLOGY MARKET: BY REGION 2022-2034 (USD MN)

  • 8.1. Regional Outlook
  • 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.2.1 By Product
    • 8.2.2 By Technology
    • 8.2.3 By Application
    • 8.2.4 By End-user
    • 8.2.5 United States
    • 8.2.6 Canada
    • 8.2.7 Mexico
  • 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.3.1 By Product
    • 8.3.2 By Technology
    • 8.3.3 By Application
    • 8.3.4 By End-user
    • 8.3.5 United Kingdom
    • 8.3.6 France
    • 8.3.7 Germany
    • 8.3.8 Italy
    • 8.3.9 Russia
    • 8.3.10 Rest Of Europe
  • 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.4.1 By Product
    • 8.4.2 By Technology
    • 8.4.3 By Application
    • 8.4.4 By End-user
    • 8.4.5 India
    • 8.4.6 Japan
    • 8.4.7 South Korea
    • 8.4.8 Australia
    • 8.4.9 South East Asia
    • 8.4.10 Rest Of Asia Pacific
  • 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.5.1 By Product
    • 8.5.2 By Technology
    • 8.5.3 By Application
    • 8.5.4 By End-user
    • 8.5.5 Brazil
    • 8.5.6 Argentina
    • 8.5.7 Peru
    • 8.5.8 Chile
    • 8.5.9 Rest of Latin America
  • 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.6.1 By Product
    • 8.6.2 By Technology
    • 8.6.3 By Application
    • 8.6.4 By End-user
    • 8.6.5 Saudi Arabia
    • 8.6.6 UAE
    • 8.6.7 Israel
    • 8.6.8 South Africa
    • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

  • 9.1. Recent Developments
  • 9.2. Company Categorization
  • 9.3. Supply Chain & Channel Partners (based on availability)
  • 9.4. Market Share & Positioning Analysis (based on availability)
  • 9.5. Vendor Landscape (based on availability)
  • 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL AI IN PATHOLOGY INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Company Profiles
    • 10.2.1 Koninklijke Philips N.V
    • 10.2.2 PathAI Inc
    • 10.2.3 Aignostics GmbH
    • 10.2.4 Hologic Inc
    • 10.2.5 F. Hoffmann-La Roche Ltd
    • 10.2.6 Aiforia Technologies Plc
    • 10.2.7 Ibex Medical Analytics Inc
    • 10.2.8 Paige Inc
    • 10.2.9 Proscia Inc
    • 10.2.10 Indica Labs Inc
    • 10.2.11 FUJIFILM Healthcare Americas Corporation (formerly Capturing Inspirata Inc.'s Asset Portfolio)